Cancer Family
Oral Neoplasm
CI-CAN-00000301Explore in graph →
Non-malignant163 active trials2 evidence items
- NCIt
- C8989
Loading cancer entity…
Cancer Family
CI-CAN-00000301Explore in graph →
Clinical trials
604 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00594724 | Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging | completed | N/A | 99 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 12, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 |
| Jun 11, 2014 |
| clinicaltrials |
| NCT00049283 | Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2014 | clinicaltrials |
| NCT00103259 | Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 71 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00492089 | Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00513435 | Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 9 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT01946230 | The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma(p62/SQSTM1) | unknown | — | 2,000 | National Taiwan University HospitalOTHER | 0 | Apr 28, 2014 | clinicaltrials |
| NCT01919580 | Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor. | unknown | — | 255 | National Taiwan University HospitalOTHER | 1 | Apr 15, 2014 | clinicaltrials |
| NCT02009852 | The Role of microRNA-29b in the Oral Squamous Cell Carcinoma(microRNA-29b) | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT01728480 | Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Dec 11, 2013 | clinicaltrials |
| NCT01919567 | Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer. | unknown | — | 255 | National Taiwan University HospitalOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01987934 | Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma(OSCC) | unknown | — | 60 | Academy of Interdisciplinary Dental Education and ResearchOTHER | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00006106 | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00780312 | Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer(HOHF) | completed | Phase 2 | 97 | Rigshospitalet, DenmarkOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00906360 | Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01155609 | L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer | completed | N/A | 10 | University of WashingtonOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT01854021 | Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer | unknown | N/A | 60 | tiejun ZhangOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT01674374 | Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | May 15, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00096512 | S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00033618 | Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck | completed | Phase 2 | 144 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00023959 | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00077428 | Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00064103 | Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx | completed | Phase 1 / Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00068497 | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer | completed | N/A | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00951470 | Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Sep 7, 2012 | clinicaltrials |
| NCT00502125 | In Vivo Confocal Imaging of Oral Mucosa | completed | — | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00502580 | Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions | completed | — | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01649349 | The Feasibility Study of Dual-Section Nasogastric Tube | completed | Early Phase 1 | 10 | Changhua Christian HospitalOTHER | 0 | Jul 25, 2012 | clinicaltrials |
| NCT01637194 | Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer | completed | Phase 1 | 12 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2012 | clinicaltrials |
| NCT01321892 | Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium | completed | — | 64 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Jun 21, 2012 | clinicaltrials |
| NCT00232960 | Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC | unknown | N/A | 310 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01561534 | Vascularized Free Fibula Flap and Computer-guided Implant Surgery | unknown | — | 5 | University of BariOTHER | 1 | Mar 23, 2012 | clinicaltrials |
| NCT01351532 | Behavior Change on Oral Cancer Patients After a Localized Behavior Change Model Intervention | completed | N/A | 67 | China Medical University HospitalOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00410865 | Wild Type p53 Adenovirus for Oral Premalignancies | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00158652 | Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC | completed | Phase 3 | 840 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Nov 8, 2011 | clinicaltrials |
| NCT01418118 | Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery(Free4Flow) | completed | Phase 4 | 25 | Oxford University Hospitals NHS TrustOTHER | 1 | Aug 16, 2011 | clinicaltrials |
| NCT01077869 | A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis | terminated | — | 10 | University Hospital, GhentOTHER | 1 | May 26, 2011 | clinicaltrials |
| NCT01136265 | PET/CT and Sentinel Node in Oral Cancer(PETNode) | unknown | — | 70 | Rigshospitalet, DenmarkOTHER | 1 | Jan 11, 2011 | clinicaltrials |
| NCT00767442 | Least Invasive Nonlinear Light Microscopy | unknown | — | 10 | National Taiwan University HospitalOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00655421 | Oral Cancer Screening in Mumbai, India by Primary Health Care Workers | unknown | Phase 3 | 329 | Tata Memorial HospitalOTHER_GOV | 1 | Jul 3, 2009 | clinicaltrials |
| NCT00750503 | Workplace Tobacco Cessation And Oral Cancer Screening Study | completed | Phase 3 | 104 | Tata Memorial HospitalOTHER_GOV | 1 | Sep 10, 2008 | clinicaltrials |
| NCT00200837 | Ethnopharmacological Studies in Oral Medicine | completed | — | 1,000 | National Center for Complementary and Integrative Health (NCCIH)NIH | 3 | Mar 28, 2007 | clinicaltrials |
| NCT00173381 | The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Mar 30, 2006 | clinicaltrials |
| NCT00193843 | Oral Cancer Adjuvant Therapy (OCAT) Trial | unknown | Phase 3 | 900 | Tata Memorial HospitalOTHER_GOV | 1 | Dec 26, 2005 | clinicaltrials |
| NCT00172965 | Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography | unknown | — | 60 | National Taiwan University HospitalOTHER | 1 | Sep 15, 2005 | clinicaltrials |
| NCT00173316 | Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions | unknown | — | 80 | National Taiwan University HospitalOTHER | 1 | Sep 15, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jun 12, 2014source: clinicaltrials